Potential diabetic cardiomyopathy therapies targeting pyroptosis: A mini review
Pyroptosis is primarily considered a pro-inflammatory class of caspase-1- and gasdermin D (GSDMD)-dependent programmed cell death. Inflammasome activation promotes the maturation and release of interleukin (IL)-1β and IL-18, cleavage of GSDMD, and development of pyroptosis. Recent studies have repor...
Main Authors: | Yu Jia, Dongze Li, Jing Yu, Wenli Jiang, Xiaoyang Liao, Qian Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.985020/full |
Similar Items
-
Role of pyroptosis in diabetic cardiomyopathy: an updated review
by: Gan Wang, et al.
Published: (2024-01-01) -
NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy
by: Lixia Zhang, et al.
Published: (2022-09-01) -
Aloe-Emodin Derivative, an Anthraquinone Compound, Attenuates Pyroptosis by Targeting NLRP3 Inflammasome in Diabetic Cardiomyopathy
by: Yingying Hu, et al.
Published: (2023-09-01) -
Mini-Review: GSDME-Mediated Pyroptosis in Diabetic Nephropathy
by: Wen Li, et al.
Published: (2021-11-01) -
Cyclovirobuxine D Ameliorates Experimental Diabetic Cardiomyopathy by Inhibiting Cardiomyocyte Pyroptosis via NLRP3 in vivo and in vitro
by: Ge Gao, et al.
Published: (2022-07-01)